Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
CompletedNot applicableNCT03638856
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Research objective To compare effectiveness of oral Misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy Research hypothesis: Null hypothesis Effectiveness of oral misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy is not different from placebo Alternative hypothesis: : Oral Misoprostal for cervical priming in Premenopausal women underwent to diagnostic hysteroscopy is better than placebo
Study details
- Official title
- Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Premenopausal Women Underwent to Diagnostic Hysteroscopy: Double-blind, Randomized Placebo-Controlled Trial
- Conditions
- Abnormal Uterine Bleeding
- Chronic Pelvic Pain
- Infertility, Female
- Interventions
- Drug: Misoprostol 200Mcg Tab
- Sponsor
- Department of Medical Services Ministry of Public Health of Thailand
- Start date
- 2018-09-30
- Primary completion
- 2018-12-30
- Sex
- Female
- Age range
- from 18 Years to 45 Years
- Results posted
- No results posted in this snapshot
- Countries
- Thailand
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Premenopausal women 2. Patients have following indication for diagnosis hysteroscopy * Abnormal uterine bleeding * Unexplained infertility * Recurrent pregnancy loss * Chronic pelvic pain * Late postpartum hemorrhage 3. Patients provided written informed consent Exclusion Criteria: 1. Postmenopausal women 2. Patients who have contraindication for Misoprostal as following * Allergic to Misoprostal * Medical illnesses such as cardiovascular diseases, Asthma, Renal disease 3. Patients who have contraindication for Hysteroscopoy as following * Pregnant women * Pelvic inflammatory disease * Infection at cervix and vagina * Cervical cancer
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03638856